抗生素预防-在高死亡率的贫穷国家预防严重感染和拯救生命。
Antibiotic prophylaxis-Preventing severe infections and saving lives in poor countries with very high mortality risk.
机构信息
Pneumonia Program Strategy Team, Bill and Melinda Gates Foundation, Seattle, Washington, United States of America.
Maternal Neonatal, Child Health Discovery and Tools Program Strategy Team, Bill and Melinda Gates Foundation, Seattle, Washington, United States of America.
出版信息
PLoS Med. 2018 Jun 26;15(6):e1002594. doi: 10.1371/journal.pmed.1002594. eCollection 2018 Jun.
Abstract
In a Perspective, Keith P. Klugman and Rasa Izadnegahdar from the Bill and Melinda Gates Foundation discuss the potentials and risks of antibiotic prophylaxis interventions for infectious disease outbreaks in rural regions, such as sub-Saharan Africa with very high mortality rates, when primary prophylactic vaccination programs are not yet available.
摘要
在一篇观点文章中，比尔及梅琳达·盖茨基金会的 Keith P. Klugman 和 Rasa Izadnegahdar 探讨了在撒哈拉以南非洲等地区，当初级预防性疫苗接种计划尚未实施时，抗生素预防干预措施在传染病暴发方面的潜力和风险。这些地区的死亡率非常高。
相似文献
1
Antibiotic prophylaxis-Preventing severe infections and saving lives in poor countries with very high mortality risk.抗生素预防-在高死亡率的贫穷国家预防严重感染和拯救生命。
PLoS Med. 2018 Jun 26;15(6):e1002594. doi: 10.1371/journal.pmed.1002594. eCollection 2018 Jun.
2
Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.加纳针对流行性脑膜炎的应急疫苗接种：对西非脑膜炎球菌病控制的影响
Lancet. 2000 Jan 1;355(9197):30-3. doi: 10.1016/S0140-6736(99)03366-8.
3
"Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.《爱的徒劳》：撒哈拉以南非洲未能实施针对A群脑膜炎球菌性脑膜炎的大规模疫苗接种
Lancet. 1997 Sep 20;350(9081):880-2. doi: 10.1016/S0140-6736(97)03227-3.
4
[Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine].[撒哈拉以南非洲的脑膜炎球菌性脑膜炎疫情与A群脑膜炎球菌结合疫苗]
Med Sante Trop. 2012 Jul-Sep;22(3):246-58. doi: 10.1684/mst.2012.0086.
5
A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine.反驳意见：目前，通过使用A群脑膜炎球菌结合疫苗进行常规免疫接种，可以预防撒哈拉以南非洲地区的流行性和地方性脑膜炎球菌性脑膜炎。
Pediatr Infect Dis J. 2000 Oct;19(10):945-53. doi: 10.1097/00006454-200010000-00001.
6
Control of meningococcal meningitis outbreaks in sub-Saharan Africa.撒哈拉以南非洲地区脑膜炎球菌性脑膜炎疫情的控制
J Infect Dev Ctries. 2008 Oct 1;2(5):335-45. doi: 10.3855/jidc.193.
7
Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study.南亚和撒哈拉以南非洲地区基于人群的孕产妇死亡、死产和新生儿死亡的发生率、时间和原因：一项多国前瞻性队列研究。
Lancet Glob Health. 2018 Dec;6(12):e1297-e1308. doi: 10.1016/S2214-109X(18)30385-1. Epub 2018 Oct 22.
8
Meningitis epidemics shift in sub-Saharan belt.撒哈拉以南地区的脑膜炎疫情发生转移。
Int J Infect Dis. 2018 Mar;68:79-82. doi: 10.1016/j.ijid.2018.01.020. Epub 2018 Mar 1.
9
Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.撒哈拉以南非洲地区的脑膜炎球菌性脑膜炎：使用现有多糖疫苗进行大规模和常规疫苗接种的理由。
Bull World Health Organ. 2003;81(10):745-50; discussion 751-5. Epub 2003 Nov 25.
10
Meningococcal vaccination for international travellers from Greece visiting developing countries.脑膜炎球菌疫苗接种：针对来自希腊、前往发展中国家的国际旅行者。
Travel Med Infect Dis. 2016 May-Jun;14(3):261-6. doi: 10.1016/j.tmaid.2016.03.001. Epub 2016 Mar 10.
本文引用的文献
1
Single-dose oral ciprofloxacin prophylaxis as a response to a meningococcal meningitis epidemic in the African meningitis belt: A 3-arm, open-label, cluster-randomized trial.单剂量口服环丙沙星预防措施应对非洲脑膜炎带的脑膜炎球菌性脑膜炎流行：一项 3 臂、开放性标签、整群随机试验。
PLoS Med. 2018 Jun 26;15(6):e1002593. doi: 10.1371/journal.pmed.1002593. eCollection 2018 Jun.
2
Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.阿奇霉素降低撒哈拉以南非洲儿童死亡率
N Engl J Med. 2018 Apr 26;378(17):1583-1592. doi: 10.1056/NEJMoa1715474.
3
Mapping under-5 and neonatal mortality in Africa, 2000-15: a baseline analysis for the Sustainable Development Goals.绘制 2000-2015 年非洲 5 岁以下儿童和新生儿死亡率地图：可持续发展目标的基线分析。
Lancet. 2017 Nov 11;390(10108):2171-2182. doi: 10.1016/S0140-6736(17)31758-0. Epub 2017 Sep 25.
4
Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals.2000 - 2015年全球、区域和国家五岁以下儿童死亡原因：一项最新的系统分析及其对可持续发展目标的启示
Lancet. 2016 Dec 17;388(10063):3027-3035. doi: 10.1016/S0140-6736(16)31593-8. Epub 2016 Nov 11.
5
Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004-2013.2004 - 2013年非洲脑膜炎带的脑膜炎球菌性脑膜炎监测
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S410-5. doi: 10.1093/cid/civ597.
6
Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States.基于人群的美国脑膜炎奈瑟菌抗菌药物耐药性监测。
Open Forum Infect Dis. 2015 Aug 13;2(3):ofv117. doi: 10.1093/ofid/ofv117. eCollection 2015 Sep.
7
Evidence for clonal expansion after antibiotic selection pressure: pneumococcal multilocus sequence types before and after mass azithromycin treatments.抗生素选择压力后克隆扩增的证据：大规模阿奇霉素治疗前后的肺炎球菌多位点序列类型
J Infect Dis. 2015 Mar 15;211(6):988-94. doi: 10.1093/infdis/jiu552. Epub 2014 Oct 6.
8
Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].A 群脑膜炎奈瑟球菌结合疫苗（PsA-TT）对乍得 A 群脑膜炎奈瑟球菌脑膜炎和带菌的影响：一项社区研究[已更正]。
Lancet. 2014 Jan 4;383(9911):40-47. doi: 10.1016/S0140-6736(13)61612-8. Epub 2013 Sep 12.
Zotero 插件